| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
19,055 |
13,931 |
$623K |
| 87428 |
|
4,721 |
3,798 |
$212K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,056 |
4,000 |
$128K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,134 |
4,680 |
$101K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,467 |
2,687 |
$56K |
| 99000 |
|
12,333 |
9,410 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,490 |
1,319 |
$33K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,955 |
2,389 |
$29K |
| 86328 |
|
37 |
34 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
16 |
14 |
$863.81 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$528.72 |